Post-IPO Equity - Eiger BioPharmaceuticals - Apr 29, 2016 Funding Round Profile - Cointime

Bitcoin $90,384.93 +1.01%
Ethereum $3,067.89 +0.79%
BNB $897.54 +0.52%
Optimism $0.31 -3.98%
Arbitrum $0.20 -2.80%
Solana $131.96 -0.40%
Polygon $0.22 +2.77%
Cosmos $2.18 -2.77%
Avalanche $13.42 -0.56%

Bitcoin $90,384.93 +1.01%
Ethereum $3,067.89 +0.79%
BNB $897.54 +0.52%
Optimism $0.31 -3.98%
Arbitrum $0.20 -2.80%
Solana $131.96 -0.40%
Polygon $0.22 +2.77%
Cosmos $2.18 -2.77%
Avalanche $13.42 -0.56%

Eiger BioPharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 2.99M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 25, 2009	Series A	$ 8.30M	InterWest Partners,Vivo Capital	Detail
Nov 23, 2015	Debt Financing	$ 6M		Detail
Apr 15, 2011	Series A	$ 14.46M	InterWest Partners,Vivo Capital	Detail
Jan 1, 2007	Seed	0	RA Capital Management	Detail
Mar 21, 2016	Debt Financing	0	InterWest Partners	Detail
Mar 23, 2016	IPO	0		Detail